Advertisement

Complementation Analysis of Peroxisomal Diseases: Kinetics of Assembly of Peroxisomes After Fusion of Complementary Cell Lines from Patients Deficient in Peroxisomes

  • S. Brul
  • E. A. C. Wiemer
  • A. Strijland
  • H. S. A. Heymans
  • R. B. H. Schutgens
  • H. Van Den Bosch
  • A. W. Schram
  • R. J. A. Wanders
  • A. Westerveld
  • J. M. Tager
Part of the NATO ASI Series book series (NSSA, volume 150)

Abstract

In 1973, Sidney Goldfischer and his colleagues published their seminal paper [l] in which they reported that peroxisomes are deficient in liver and kidney of patients with the cerebro-hepato-renal (Zellweger) syndrome. In fact, in the two patients initially studied, morphologically distinguisable peroxisomes appeared to be totally lacking [l]. These observations, which were later confirmed in many laboratories, pointed to a hitherto unsuspected situation: a genetic disease in man in which a complete organelle is deficient. Borst [2] subsequently suggested that the pathogenesis of the Zellweger syndrome might be due simply to the absence of peroxisomes (see also Ref. 3), a postulate now amply validated by the realization of the essential role of peroxisomes in a number of metabolic pathways. Indeed, the deficiency of peroxisomes in the Zellweger syndrome is accompanied by a generalized impairment of peroxisomal functions, due to a deficiency of many peroxisomal enzymes [4–9]. The metabolic pathways in which peroxisomes play an essential role are listed in Table I.

Keywords

Phytanic Acid Complementation Group Pipecolic Acid Zellweger Syndrome Peroxisomal Enzyme 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Goldfischer, S., Moore, C.L., Johnson, A.B., Spiro, A.J., Valsamis, M.P., Wisniewski, H.K., Ritch, R.H., Norton, W.T., Rapin, I. and Gartner, L.M. (1973) Peroxisomal and mitochondrial defects in the cerebro-hepato-renal syndrome, Science 183, 62–64.CrossRefGoogle Scholar
  2. 2.
    Borst, P. (1983) Animal peroxisomes (microbodies), lipid biosynthesis and the Zellweger syndrome, Trends Biochem. Sci. 8, 269–272.CrossRefGoogle Scholar
  3. 3.
    Pedersen, J.I., and Gustafsson, J. (1980) Conversion of 3a, 7a, 12a-trihydroxy-5β-cholestanoic acid into cholic acid by rat liver peroxisomes, FEBS Lett. 121, 345-348.Google Scholar
  4. 4.
    Goldfischer, S., and Reddy, J.K. (1984) Peroxisomes (microbodies) in cell pathology, Int. Rev. Exp. Pathol. 26, 45-84.Google Scholar
  5. 5.
    Kelley, R.I., Dutta, N.S., Dabyns, W.B., Hajra, A.K., Moser, A.B., Noetzel, M.J., Zackai, E.H., and Moser, H.W. (1986) Neonatal Adrenoleukodystrophy: New cases, biochemical studies and differentiation from Zellweger and related peroxisomal polydystrophy syndromes, Am. J. Med. Genet. 23, 869-901.Google Scholar
  6. 6.
    Schutgens, R.B.H., Heymans, H.S.A., Wanders, R.J.A., Van Den Bosch, H., and Tager, J.M. (1986) Peroxisomal disorders: A newly recognised group of genetic disease. Eur. J. Pediatr. 144, 430-440.Google Scholar
  7. 7.
    Wanders, R.J.A., Schutgens, R.B.H., Heymans, H.S.A., Collins, J., Goldfischer, S., Hashimoto, T., Schrakamp, G., Van Den Bosch, H., Tager, J.M., and Schräm, A.W. (1987) Biochemical analysis in peroxisomal disorders, in: “Peroxisomes in Biology and Medicine”, (Fahimi, H.D., and Sies, H., eds.) Springer, Berlin, pp. 341-352.Google Scholar
  8. 8.
    Moser, H.W. (1987) New approaches in peroxisomal disorders, Dev. Neurosci. 9, 1–18.PubMedCrossRefGoogle Scholar
  9. 9.
    Schutgens, R.B.H., Wanders, R.J.A., Nijenhuis, A., Van Den Hoek Heymans, H.S.A., Schrakamp, G., Bleeker-Wagemaker, E.M., Delleman, J.W., Schräm, A.W., Tager, J.M., and Van Den Bosch, H, (1988) Genetic disease caused by peroxisomal dysfunction. New findings in clinical and biochemical studies, Enzyme, in press.Google Scholar
  10. 10.
    Lazarow, P.B., and DeDuve, C. (1976) A fatty acyl-CoA oxidizing system in rat liver peroxisomes: Enhancement by Clofibrate, a hypolipidemic drug, Proc. Natl. Acad. Sci. USA 73, 2043–2046.PubMedCrossRefGoogle Scholar
  11. 11.
    Bremer, J. (1977) Carnitine and its role in fatty acid metabolism, Trends. Biochem. Sci. 2, 207–209.Google Scholar
  12. 12.
    Singh, I., Moser, A.E., Goldfischer, S., and Moser, H.W., (1984) Lignoceric acid is oxidized in the peroxisomes: Implications for the Zellweger cerebro-hepato-renal syndrome and adrenoleukodystrophy, Proc. Natl. Acad. Sci. USA. 81, 4203-4207.Google Scholar
  13. 13.
    Hajra, A.K., and Bishop, J.E. (1982) Glycerolipid biosynthesis in peroxisomes via the acyl dihydroxyacetone phosphate pathway, Ann. N.Y. Acad. Sci. 386, 170–182.PubMedCrossRefGoogle Scholar
  14. 14.
    Kase, F., Björkhem, I., and Pedersen, J.I. (1983) Formation of cholic acid from 3a, 7a, 12a-trihydroxy-5β-cholestanoia acid by rat liver peroxisomes. J. lipid. Res. 24, 1560–1567.PubMedGoogle Scholar
  15. 15.
    Hagey, L.R., and Krlsans, S.K. (1982) Degradation of cholesterol to propionic acid by rat liver peroxisomes Biochem. Biophys. Res. Commun. 107, 834-841.Google Scholar
  16. 16.
    Diczfalusy, U., Alexson, S.E.H., and Pedersen, J.I., (1987) Chainshortening of prostaglandin F2a by rat liver peroxisomes, Biochem. Biophys. Res. Commun. 144, 1206–1213.PubMedCrossRefGoogle Scholar
  17. 17.
    Trijbels, J.M.F., Monnens, L.A.H., Melis, G., Van Den Broek-Van Essen, M., and Bruckwilder, M. (1987) Location of pipecolic acid metabolism in rat liver peroxisomes: Probable explanation for hyperpipecolataemia in Zellweger syndrome, J. Inher. Metab. Dis. 10, 128-134.Google Scholar
  18. 18.
    Poulos, A., Sharp, F., and Whiting, M. (1984) Infantile Refsum’s disease (phytanic acid storage disease). A variant of Zellweger syndrome?, Clin. Genet. 26, 5790-586.Google Scholar
  19. 19.
    Noguchi, T., and Takada, Y. (1979) Peroxisomal localisation of alanine: glyoxylate aminotransferase in human liver, Arch. Biochem. Biophys. 196, 645-647.Google Scholar
  20. 20.
    Danpure, C.J., and Jennings, P.R. (1986) Peroxisomal alanine: glyoxylate aminotranferase deficiency in primary hyperoxaluria type 1, FEBS Lett. 201, 20-24.Google Scholar
  21. 21.
    Poll-Thg, B.-T., Saudubray, J.M., Ogier, H., Schutgens, R.B.H., Wanders, R.J.A., Schrakamp, G., Van Den Bosch, H., Trijbels, J.M.F., Poulos, A., Moser, H.W., Van Eldere, J., and Eyssen, H.J. (1986) Infantile Refsum disease: Biochemical findings suggesting multiple peroxisomal dysfunction, J. Inher. Metab. Dis. 9, 169-174.Google Scholar
  22. 22.
    Heymans, H.S.A., Oorthuijs, J.W.E., Nelck, G., Wanders, R.J.A., and Schutgens, R.B.H. (1985) Rhizomelic chondrodysplasia punctata: Another peroxisomal disorder. N. Engl. J. Med. 313, 187-188.Google Scholar
  23. 23.
    Heymans, H.S.A., Oorthuys, J.W.E., Nelck, G., Wanders, R.J.A., Dingemans, K.P., and Schutgens, R.B.H. (1986) Peroxisomal abnormalities in rhizomelic chondrodysplasia punctata, J. Inher. Metab. Dis. 9: suppl 2, pp. 329–331.Google Scholar
  24. 24.
    Miura, S., Mori, M., Takiguchi, M., Tatibana, M., Furuta, S., Miyazawa, T., and Hashimoto, T. (1984) Biosynthesis and intracellular transport of enzymes of peroxisomal β-oxidation. J. Biol. Chem. 259, 6397–6402.PubMedGoogle Scholar
  25. 25.
    Fujiki, Y., Rachubinski, R.A., Mortensen, R.M., and Lazarow, P.B. (1985) Synthesis of 3-ketoacyl-CoA thiolase of rat liver peroxisomes on free polyribosomes as a larger precursor. Induction of thiolase mRNA activity by Clofibrate. Biochem. J. 226, 697-704.Google Scholar
  26. 26.
    Brul S., Westerveld, A., Strijland, A., Wanders, R.J.A., Schram, A.W., Heymans, H.S.A., Schutgens, R.B.H., Van Den Bosch, H., and Tager, J.M. (1988) Genetic heterogeneity in the cerebro-hepato-renal (Zellweger) syndrome and other inherited disorders with a generalized impairment of peroxisomal functions: A study using complementation analysis. J. Clin. Invest., in press.Google Scholar
  27. 27.
    Lazarow, P.B., and Fujiki, Y. (1985) Biogenesis of peroxisomes, Ann. Ref. Cell. Biol. 1, 489-530.Google Scholar
  28. 28.
    Borst, P. (1986) Review. How proteins get into microbodies (peroxisomes, glyoxysomes, glycosomes), Biochim. Biophys. Acta 866, 179-203.Google Scholar
  29. 29.
    Wanders, R.J.A., Kos, M., Roest, B., Meijer, A.J., Schrakamp, G., Heymans, H.S.A., Tegelaers, W.H.H., Van Den Bosch, H., Schutgens, R.B.H., and Tager, J.M. (1984) Activity of peroxisomal enzymes and intracellular distibution of catalse in Zellweger syndrome, Biochem. Biophys. Res. Commun. 123, 1054–1061.PubMedCrossRefGoogle Scholar
  30. 30.
    Santos, M.J., Ojeda, J.M., Garrido, J., and Leighton, F. (1985) Peroxisomal organization in normal and cerebro-hepato-renal (Zellweger) syndrome fibroblasts, Proc. Natl. Acad. Sci. USA 82, 6556–6560.PubMedCrossRefGoogle Scholar
  31. 31.
    Wanders, R.J.A., Schutgens, R.B.H., and Tager, J.M. (1985) Peroxisomal matrix enzymes in the Zellweger syndrome: activity and subcellular localization in liver. J. Iner. Metab. Dis. 8, suppl. 1, pp. 151–152.Google Scholar
  32. 32.
    Tager, J.M., Ten Harmsen Van Der Beek, W.A., Wanders, R.J.A., Hashimoto, T., Heymans, H.S.A., Van den Bosch, H., Schutgens, R.B.H. and Schram A.W. (1985) Peroxisomal β-oxidation enzyme proteins in Zellweger syndrome. Biochem. Biophys. Res. Commun. 126, 1269–1275.PubMedCrossRefGoogle Scholar
  33. 33.
    Roscher, A., Höfler, S., Höfler, G., Paschke, E., and Paltauf, F. (1986) Neonatal adrenoleukodystrophy (NALD) and cerebrohepatorenal syndrome (CHRS): Genetic complementation analysis of impaired peroxisomal plasmalogen biosynthesis. Abstracts 24th Annual Symposium of the Society for the Study of Inborn Errors of Metabolism, Amersfoort, The Netherlands, Abstract 03.Google Scholar

Copyright information

© Plenum Press, New York 1988

Authors and Affiliations

  • S. Brul
    • 1
  • E. A. C. Wiemer
    • 1
  • A. Strijland
    • 1
  • H. S. A. Heymans
    • 2
  • R. B. H. Schutgens
    • 2
  • H. Van Den Bosch
    • 3
  • A. W. Schram
    • 1
  • R. J. A. Wanders
    • 2
  • A. Westerveld
    • 4
  • J. M. Tager
    • 1
  1. 1.Laboratory of BiochemistryUniversity of AmsterdamAmsterdamThe Netherlands
  2. 2.Department of PediatricsAcademic Medical Centre of the University of AmsterdamAmsterdamThe Netherlands
  3. 3.Laboratory of BiochemistryUniversity of UtrechtUtrechtThe Netherlands
  4. 4.Division of Cell Biology and GeneticsErasmus University RotterdamRotterdamThe Netherlands

Personalised recommendations